分次5-氨基乙酰丙酸光动力疗法与两阶段甲基氨基乙酰丙酸光动力疗法治疗浅表性基底细胞癌的随机对照试验
该单盲随机多中心试验在荷兰纳入162例浅表性基底细胞癌患者,比较分次ALA-PDT与常规MAL-PDT。ALA-PDT疼痛评分更高且治疗后副作用更多。
要点
- ALA-PDT组治疗失败6例,少于MAL-PDT组的13例。
- ALA-PDT疼痛评分更高且治疗后副作用更多。
核心结论
- 分次ALA-PDT scheme resulted in fewer recurrences, although the difference between both treatment groups was not statistically significant.
- ALA-PDT resulted in higher pain scores and more post-treatment side-effects compared with MAL-PDT.
研究设计与样本
- 单盲、随机、多中心试验,在荷兰进行,共162例患者随机分配至常规MAL-PDT或分次ALA-PDT。
主要发现
- 12个月时ALA-PDT组治疗失败6例,MAL-PDT组13例。
- ALA-PDT疼痛评分更高且治疗后副作用更多。
关键数值与推荐
- 分次ALA-PDT照明方案:ALA应用后4小时和6小时分别给予20 J cm-2和80 J cm-2两次光照。
临床怎么用
- 对于浅表性基底细胞癌,分次ALA-PDT可减少复发但未达统计学显著,且疼痛和副作用较多,需权衡利弊。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Basal cell carcinoma (BCC) is the most common type of skin cancer and incidence rates are increasing. Photodynamic therapy (PDT) is a frequently used treatment, especially for superficial BCC (sBCC). Two topical photosensitizing agents are currently used to treat sBCC, namely 5-aminolaevulinic acid (ALA) and its ester, methyl aminolaevulinate (MAL). Previous research showed a high efficacy for ALA-PDT using a twofold fractionated illumination scheme in which two light fractions of 20 J cm-2 and 80 J cm-2 were delivered 4 h and 6 h after ALA application. OBJECTIVES: To evaluate whether twofold ALA-PDT is superior to conventional MAL-PDT for sBCC. METHODS: We performed a single-blind, randomized, multicentre trial in the Netherlands. RESULTS: Overall, 162 patients were randomized either to conventional MAL-PDT or twofold ALA-PDT. After 12 months, a total of six treatment failures occurred following ALA-PDT and 13 treatment failures occurred following MAL-PDT. The 12-month cumulative probability of remaining free from treatment failure was 92·3% [95% confidence interval (CI) (83·7-96·5)] for ALA-PDT and 83·4% (95% CI 73·1-90·0) for MAL-PDT (P = 0·091). CONCLUSIONS: The twofold ALA-PDT scheme resulted in fewer recurrences, although the difference between both treatment groups was not statistically significant. However, ALA-PDT resulted in higher pain scores and more post-treatment side-effects compared with MAL-PDT.
引用
- Kessels JPHM, Kreukels H, Nelemans PJ, et al. Treatment of superficial basal cell carcinoma by topical photodynamic therapy with fractionated 5-aminolaevulinic acid 20% vs. two-stage topical methyl aminolaevulinate: results of a randomized controlled trial. Br J Dermatol. 2018. PMID: 28886209. doi:10.1111/bjd.15967
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。